Qlaris Bio, Inc., 2025-11-17
An SEC Form D private-offering notice from Dedham, MA, a $5,641,600 filer-stated offering target in Biotech. Filed 2025-11-17. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing QLS-111, a topical drug candidate to lower intraocular pressure and treat glaucoma
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Solarea Bio, Inc., 2025-11-20, Waltham, MA
- Pleural Dynamics, Inc., 2025-11-18, $4M, Wayzata, MN
- Kula Bio, Inc., 2025-11-19, $25M, Natick, MA
- Dualitas Therapeutics, Inc., 2025-11-18, $66.6M, South San Francisco, CA
- IIOT-OXYS, Inc., 2025-11-19, $1, Cambridge, MA
- VitriVax, Inc., 2025-11-17, $37.1M, Boulder, CO
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.